Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|July 29, 2024
A Pharmacovigilance Study on Clozapine in the Food and Drug Administration Adverse Event Reporting System: A Regional Comparative AnalysisMasakazu Hatano, Haruna Araki, Takeo Saito, et al.
Neuropsychiatric Disease and Treatment|December 22, 2021
Treatment Continuation of Asenapine or Olanzapine in Japanese Schizophrenia Patients: A Propensity Score Matched StudyHaruna Matsuzaki, Masakazu Hatano, Miko Iwata, et al.
Psychiatry Research|July 1, 2020
Trend survey on adverse event profiles of antipsychotic long-acting injections and oral agents using the Japanese adverse drug event report databaseMasakazu Hatano, Hiroyuki Kamei, Akane Shimato, et al.
Journal of Affective Disorders|March 24, 2026
Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysisTaro Kishi, Kenji Sakuma, Masakazu Hatano, et al.
Biological & Pharmaceutical Bulletin|July 2, 2019
Factors That Affect Continuation of Antipsychotic Long-Acting InjectionsMiko Taniguchi, Masakazu Hatano, Hiroyuki Kamei, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 29, 2026
Relapse and its modifiers after antipsychotic discontinuation in first-episode non-affective psychosis: A systematic review and meta-analysisTaro Kishi, Leslie Citrome, Kenji Sakuma, et al.
Neuropsychopharmacology Reports|July 2, 2021
Outcomes of patients with schizophrenia who discontinued long-acting injectable antipsychotic therapy due to adverse events: A chart reviewTaro Kishi, Kenji Sakuma, Makoto Okuya, et al.
Neuropsychiatric Disease and Treatment|March 22, 2023
Effectiveness of Clozapine on Employment Outcomes in Treatment-Resistant Schizophrenia: A Retrospective Bidirectional Mirror-Image StudyHaruna Matsuzaki, Masakazu Hatano, Miko Iwata, et al.
Neuropsychiatric Disease and Treatment|October 9, 2023
Clinical Laboratory Data in Japan: A Comparative Study of Patients with Psychiatric Disorders and the General PopulationMiko Iwata, Masakazu Hatano, Kana Ito, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|January 21, 2020
Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case SeriesHiroyuki Kamei, Hanae Yamada, Masakazu Hatano, et al.
Pageof 5